- Investing Ideas
- Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
67
Companies with a Value score of at least 3, ordered by Value score
67 companies
Regeneron Pharmaceuticals
Market Cap: Mex$63.1b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN *
Mex$10,835.99
7D
3.0%
1Y
10.2%
Gilead Sciences
Market Cap: Mex$153.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD *
Mex$2,203.81
7D
4.1%
1Y
4.9%
Ardelyx
Market Cap: Mex$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX *
Mex$99.00
7D
0%
1Y
n/a
United Therapeutics
Market Cap: Mex$23.1b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR *
Mex$9,680.00
7D
1.5%
1Y
n/a
Bausch Health Companies
Market Cap: Mex$2.0b
Operates as a diversified specialty pharmaceutical and medical device company.
BHC N
Mex$85.44
7D
0%
1Y
-31.1%
Vaxart
Market Cap: Mex$117.4m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT *
Mex$12.00
7D
0%
1Y
n/a
CSPC Pharmaceutical Group
Market Cap: Mex$69.4b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093 N
Mex$15.69
7D
0%
1Y
-27.0%
GSK
Market Cap: Mex$57.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK1 N
Mex$356.95
7D
0%
1Y
n/a
Zai Lab
Market Cap: Mex$3.5b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB N
Mex$810.00
7D
0%
1Y
n/a
Grifols
Market Cap: Mex$6.9b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF N
Mex$257.03
7D
0%
1Y
n/a
Zoetis
Market Cap: Mex$32.8b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS *
Mex$1,371.70
7D
0.6%
1Y
-53.6%
Genomma Lab Internacional. de
Market Cap: Mex$14.3b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$15.09
7D
3.2%
1Y
-27.7%
Novo Nordisk
Market Cap: Mex$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVOB N
Mex$775.00
7D
0.6%
1Y
-39.7%
Pfizer
Market Cap: Mex$134.9b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE *
Mex$413.87
7D
-7.4%
1Y
-9.2%
Novavax
Market Cap: Mex$1.4b
A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
NVAX *
Mex$146.00
7D
-12.4%
1Y
21.7%
Caris Life Sciences
Market Cap: Mex$5.3b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI *
Mex$317.00
7D
0%
1Y
n/a
Organon
Market Cap: Mex$3.5b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN *
Mex$229.00
7D
-1.2%
1Y
n/a
BeiGene
Market Cap: Mex$14.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
BGNE N
Mex$2,858.16
7D
0%
1Y
n/a
Perrigo
Market Cap: Mex$3.7b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO N
Mex$557.52
7D
0%
1Y
n/a
Jazz Pharmaceuticals
Market Cap: Mex$10.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ N
Mex$2,500.00
7D
0%
1Y
n/a
Viatris
Market Cap: Mex$18.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS *
Mex$282.19
7D
0%
1Y
70.0%
Novo Nordisk
Market Cap: Mex$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO N
Mex$831.50
7D
10.1%
1Y
-35.5%
Telix Pharmaceuticals
Market Cap: Mex$4.7b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX1 N
Mex$302.55
7D
0%
1Y
n/a
Bristol-Myers Squibb
Market Cap: Mex$112.3b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY *
Mex$974.50
7D
4.8%
1Y
10.7%
Astellas Pharma
Market Cap: Mex$3.8t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503 N
Mex$253.57
7D
0%
1Y
n/a
ACADIA Pharmaceuticals
Market Cap: Mex$4.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD *
Mex$362.00
7D
0%
1Y
n/a
Haleon
Market Cap: Mex$30.7b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN1 N
Mex$160.00
7D
0%
1Y
n/a
Bayer
Market Cap: Mex$46.2b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN N
Mex$779.00
7D
-0.8%
1Y
n/a
Biogen
Market Cap: Mex$29.5b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB *
Mex$3,604.56
7D
8.1%
1Y
50.3%
Fortrea Holdings
Market Cap: Mex$1.8b
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE1 *
Mex$435.30
7D
0%
1Y
n/a
Mirum Pharmaceuticals
Market Cap: Mex$3.7b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM *
Mex$1,256.12
7D
0%
1Y
n/a
AnaptysBio
Market Cap: Mex$1.3b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
ANAB *
Mex$668.00
7D
0%
1Y
n/a
GSK
Market Cap: Mex$79.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK N
Mex$901.11
7D
0%
1Y
n/a
BioCryst Pharmaceuticals
Market Cap: Mex$2.5b
A biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.
BCRX *
Mex$175.00
7D
17.0%
1Y
n/a
Sanofi
Market Cap: Mex$88.5b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN1 N
Mex$1,525.85
7D
0%
1Y
n/a
Agios Pharmaceuticals
Market Cap: Mex$2.0b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO *
Mex$1,222.00
7D
0%
1Y
n/a